Provider of medical isotopes used in diagnostic imaging and therapy.
ASP Isotopes Inc., based in Boca Raton, Florida, specializes in the advancement and commercial application of isotopes, with a primary focus on developing Molybdenum-100 and Uranium-235. Molybdenum-100 is a non-radioactive isotope utilized extensively in the medical industry for its imaging and diagnostic capabilities, contributing to advancements in healthcare technologies.
In addition to its medical applications, ASP Isotopes is actively involved in the development of Uranium-235, an isotope critical for the carbon-free energy sector. This isotope plays a pivotal role in nuclear energy production, offering a sustainable alternative to conventional fossil fuels and contributing to global efforts in reducing carbon emissions.
Established in 2021, ASP Isotopes leverages cutting-edge research and innovation to drive the commercialization of isotopic technologies. The company's strategic location in Boca Raton provides access to a robust network of scientific and technological resources, facilitating its mission to advance isotopic solutions that address significant challenges in healthcare and energy sectors worldwide.